Eyenovia Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EYENOVIA
EYENOVIA has one approved drug.
There are three US patents protecting EYENOVIA drugs.
Summary for Eyenovia
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Eyenovia
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eyenovia | MYDCOMBI | phenylephrine hydrochloride; tropicamide | SPRAY, METERED;OPHTHALMIC | 215352-001 | May 5, 2023 | DISCN | Yes | No | 11,839,487 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Eyenovia | MYDCOMBI | phenylephrine hydrochloride; tropicamide | SPRAY, METERED;OPHTHALMIC | 215352-001 | May 5, 2023 | DISCN | Yes | No | 10,839,960 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Eyenovia | MYDCOMBI | phenylephrine hydrochloride; tropicamide | SPRAY, METERED;OPHTHALMIC | 215352-001 | May 5, 2023 | DISCN | Yes | No | 11,398,306 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Eyenovia | MYDCOMBI | phenylephrine hydrochloride; tropicamide | SPRAY, METERED;OPHTHALMIC | 215352-001 | May 5, 2023 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Eyenovia Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2011278934 | ⤷ Start Trial |
| South Korea | 101545413 | ⤷ Start Trial |
| Eurasian Patent Organization | 201390121 | ⤷ Start Trial |
| Japan | 2016154868 | ⤷ Start Trial |
| Spain | 2835886 | ⤷ Start Trial |
| Mexico | 2013000604 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Eyenovia Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1534313 | 2015/071 | Ireland | ⤷ Start Trial | PRODUCT NAME: AN OCULAR IRRIGATION SOLUTION COMPRISING PHENYLEPHRINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND KETOROLAC OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/15/1018 20150728 |
| 1534313 | 15C0090 | France | ⤷ Start Trial | PRODUCT NAME: SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/15/1018 20150728 |
| 1534313 | 92923 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: UNE SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION: 20150730 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
